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Abstract
Background: After observing persistently low CD4 counts at initial HIV diagnosis in South Africa, we sought to determine
risk factors for late-stage HIV disease presentation among adults.
Methods: We surveyed adults prior to HIV testing at four outpatient clinics in Durban from August 2010 to November 2011.
All HIV-infected adults were offered CD4 testing, and late-stage HIV disease was defined as a CD4 count ,100 cells/mm
3.
We used multivariate regression models to determine the effects of sex, emotional health, social support, distance from
clinic, employment, perceived barriers to receiving healthcare, and foregoing healthcare to use money for food, clothing, or
housing (‘‘competing needs to healthcare’’) on presentation with late-stage HIV disease.
Results: Among 3,669 adults screened, 830 were enrolled, newly-diagnosed with HIV and obtained a CD4 result. Among
those, 279 (33.6%) presented with late-stage HIV disease. In multivariate analyses, participants who lived $5 kilometers
from the test site [adjusted odds ratio (AOR) 2.8, 95% CI 1.7–4.7], reported competing needs to healthcare (AOR 1.7, 95% CI
1.2–2.4), were male (AOR 1.7, 95% CI 1.2–2.3), worked outside the home (AOR 1.5, 95% CI 1.1–2.1), perceived health service
delivery barriers (AOR 1.5, 95% CI 1.1–2.1), and/or had poor emotional health (AOR 1.4, 95% CI 1.0–1.9) had higher odds of
late-stage HIV disease presentation.
Conclusions: Independent risk factors for late-stage HIV disease presentation were from diverse domains, including
geographic, economic, demographic, social, and psychosocial. These findings can inform various interventions, such as
mobile testing or financial assistance, to reduce the risk of presentation with late-stage HIV disease.
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Introduction
South Africa has more HIV-infected people than any other
country, and over 1.4 million South Africans are now receiving
antiretroviral therapy (ART) [1,2]. However, despite this progress,
45–51% of ART-eligible people are still not receiving treatment
[1,3]. Not only do these HIV-infected people constitute nearly
one-quarter of all AIDS-related deaths in sub-Saharan Africa, but
they also transmit HIV to others [1]. Furthermore, late-stage HIV
disease at initial HIV diagnosis has been associated with poor
treatment response rates and higher mortality [4–11]. In August
2011, the South African Department of Health increased the ART
initiation threshold from CD4,200 to ,350 cells/mm
3 to help
reduce AIDS-related deaths [12]. However, the median CD4
PLOS ONE | www.plosone.org 1 January 2013 | Volume 8 | Issue 1 | e55305Table 1. Characteristics of HIV-infected adults with and without late-stage disease (CD4,100 cells/mm
3) at the time of initial HIV
diagnosis in a study of HIV testing in South Africa (N=830).
Variable
Total Cohort
N( % )
Presented with late-stage
HIV disease
N( % )
Presented without late-stage
HIV disease
N (%) p-value
Demographics
Age $40 years 249 (30.0) 95 (34.1) 154 (27.9) 0.070
Age ,40 years 581 (70.0) 184 (65.9) 397 (72.1)
Male 415 (50.0) 159 (57.0) 256 (46.5) 0.004
Female 415 (50.0) 120 (43.0) 295 (53.5)
Education
Did not complete high school 449 (54.1) 162 (58.1) 287 (52.1) 0.103
Did complete high school 381 (45.9) 117 (41.9) 264 (47.9)
Marital Status 0.137
Never married 666 (80.2) 220 (78.9) 446 (80.9)
Currently married 123 (14.8) 41 (14.7) 82 (14.9)
Divorced/separated 13 (1.6) 3 (1.1) 10 (1.8)
Widowed 28 (3.4) 15 (5.4) 13 (2.4)
If not married, in current relationship? 0.643
No 226 (32.0) 80 (33.6) 146 (31.1)
Yes, ,6 months 84 (11.9) 25 (10.5) 59 (12.6)
Yes, $6 months 397 (56.2) 133 (55.9) 264 (56.3)
Employment
Currently working outside home 469 (56.5) 168 (60.2) 301 (54.6) 0.125
Not currently working outside home 361 (43.5) 111 (39.8) 250 (45.4)
Working ,20 hours outside home 32 (6.8) 18 (10.7) 14 (4.7) 0.013
Working $20 hours outside home 437 (93.2) 150 (89.3) 287 (95.3)
Proximity to the HIV Clinic
Distance to clinic $5 kilometers 688 (82.9) 257 (92.1) 431 (78.2) ,0.0001
Distance to clinic ,5 kilometers 142 (17.1) 22 (7.9) 120 (21.8)
Travel time to clinic $30 minutes 303 (36.5) 107 (38.4) 196 (35.6) 0.432
Travel time to clinic ,30 minutes 527 (63.5) 172 (61.6) 355 (64.4)
Health Care Usage
No prior HIV testing 661 (79.7) 237 (85.0) 424 (77.1) 0.008
Any prior HIV testing 168 (20.3) 42 (15.0) 126 (22.9)
Any overnight hospital stay in last year 60 (7.2) 27 (9.7) 33 (6.0) 0.053
No overnight hospital stay in last year 770 (92.8) 252 (90.3) 518 (94.0)
Emotional Health and Social Support
Poor Emotional Health (, median value) 399 (48.1) 157 (56.3) 242 (43.9) ,0.001
Good Emotional Health ($ median value) 431 (51.9) 122 (43.7) 309 (56.1)
Poor Social Support (, median value) 416 (50.1) 163 (58.4) 253 (45.9) ,0.001
Good Social Support ($ median value) 414 (49.9) 116 (41.6) 298 (54.1)
Competing Needs to Healthcare
Gone without healthcare because needed
money for food, clothing, or housing
227 (27.3) 90 (32.3) 137 (24.9) 0.024
Never gone without healthcare because needed
money for food, clothing, or housing
603 (72.6) 189 (67.7) 414 (75.1)
Foregone food, clothing, or housing because
needed money for healthcare
196 (23.6) 75 (26.9) 121 (22.0) 0.115
Never foregone food, clothing, or housing
because needed money for healthcare
634 (76.4) 204 (73.1) 430 (78.0)
Study Site 0.001
McCord Hospital 437 (52.7) 168 (60.2) 269 (48.8)
Late-Stage HIV Disease Presentation
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3 in a recent
large South African cohort [4].
Increasing the CD4 count treatment threshold will have little
benefit if the majority of people continue to present with
dangerously low CD4 counts and late-stage HIV disease.
Strategies to reduce AIDS-related mortality and decrease HIV
transmission must include earlier diagnosis of HIV [13], which has
been shown to improve survival [14]. Intensified efforts to promote
early diagnosis of HIV-infected people in resource-limited settings
are needed, but little is known about how to best target people in
HIV testing campaigns [15,16]. We conducted a large, prospective
study to assess both the real and perceived barriers to presenting
for HIV care in South Africa.
Methods
Sites and participants
We studied adults who presented for voluntary HIV counseling
and testing at four outpatient clinical sites in Durban from August
2010 to November 2011. McCord Hospital is an urban, state-
aided general hospital that serves the greater Durban area. St.
Mary’s Hospital in Mariannhill is a state-aided general hospital
that serves a resource-limited population in a peri-urban area of
Durban. Both McCord Hospital and St. Mary’s Hospital have
high-volume outpatient HIV clinics that have been providing
ART since 2001 and 2003, respectively, and receiving President’s
Emergency Plan for AIDS Relief (PEPFAR) support since 2004.
The other two sites, Tshelimnyama and Marianridge, are
municipal primary health clinics located within the catchment
Table 1. Cont.
Variable
Total Cohort
N( % )
Presented with late-stage
HIV disease
N( % )
Presented without late-stage
HIV disease
N (%) p-value
St. Mary’s Hospital 281 (33.9) 88 (31.5) 193 (35.0)
Municipal Clinics 112 (13.5) 23 (8.2) 89 (16.2)
doi:10.1371/journal.pone.0055305.t001
Figure 1. Competing needs to receiving healthcare among those with and without late-stage disease (CD4,100 cells/mm
3) at the
time of initial HIV diagnosis (N=830). Error bars represent 95% confidence intervals.
doi:10.1371/journal.pone.0055305.g001
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all four outpatient sites offered free HIV counseling and testing
during normal working business hours.
We offered enrollment to all adults $18 years of age prior to
HIV counseling and testing. We excluded those already known to
be HIV-infected, pregnant, or unwilling to share their HIV test
result with the research team. HIV testing, as well as participation
in the study, carried no financial costs to the participant. All
participants provided written informed consent either in English or
Zulu. The study was approved by the ethics committees of
McCord Hospital and St. Mary’s Hospital in Durban, and
Partners HealthCare (Protocol #: 2006-P-001379) in Boston.
Data collection
We asked participants about personal demographics, proximity
to the HIV clinic, and prior healthcare usage and HIV testing. We
recorded responses to 12 questions related to perceived personal
barriers for seeking HIV testing and medical care during the prior
6 months [17]. We asked 5 questions about emotional health over
the previous month with each response rated on a 6-point Likert
scale (ranging from 1 being ‘‘all of the time’’ or ‘‘always’’ to 6
being ‘‘none of the time’’ or ‘‘never’’). These questions, which
were adapted from the 5-item Mental Health Inventory (MHI-5)
screening test, were used to calculate a mental health composite
(MHC) score [18]. We asked 13 questions about availability of
personal social support with each response rated on a 5-point
Likert scale (ranging from 1 being ‘‘none of the time’’ to 5 being
‘‘all of the time’’). These questions incorporate four social support
scales (emotional/informational, tangible, positive interaction,
affectionate), and were used to calculate the Social Support Index
(SSI), from the Medical Outcomes Study [19]. Both the MHC and
SSI scores were independently averaged and then transformed to
scores ranging from 1 to 100, with higher numbers signifying
better emotional health and more social support. We asked
participants if they had gone without food, clothing, or housing
(‘‘basic necessities’’) during the prior 6 months because they
needed money for healthcare, or if they had foregone healthcare
during the prior 6 months because they needed money for food,
clothing, or housing [20].
After completing the survey, participants were offered free HIV
counseling and testing, and HIV-infected participants were offered
free CD4 count testing. Those who tested positive for HIV were
referred for appropriate care and treatment. All HIV testing, care,
and treatment was provided in accordance with current South
African Department of Health HIV testing and treatment
guidelines [3].
Statistical analyses
Late-stage HIV disease presentation was defined as a CD4
count ,100 cells/mm
3 at the time of initial HIV diagnosis. To
allow incorporation of the perceived barriers into multivariate
models, while also minimizing possible collinearity, we categorized
the 12 barriers into 5 groups (service delivery, financial, personal
health perception, logistical, and structural). Service delivery
barriers included ‘‘have to wait too long to see the nurse/doctor,’’
‘‘the nurse/doctor does not speak my language,’’ and ‘‘not treated
with respect by the nurse/doctor.’’ Financial barriers included
‘‘could not afford medications’’ and ‘‘could not afford the cost of
transportation.’’ Personal health perception barriers included
‘‘didn’t think it was necessary, because didn’t feel sick’’ and ‘‘felt
too sick.’’ Logistical barriers included ‘‘could not get time off
work’’ and ‘‘had to take care of someone else.’’ Structural barriers
included ‘‘could not get to the clinic during the hours it was open,’’
‘‘could not arrange transport to the clinic,’’ and ‘‘did not know
where to find care.’’ Poor emotional health and poor social
support were defined as an MHC and SSI score below the median
value, respectively.
We used Chi-squared and Fisher’s Exact tests to compare
potential risk factors between those presenting with and without
late-stage HIV disease. We used an iterative model building
approach to construct a series of logistic regression models to
identify factors associated with late-stage disease presentation.
First, we used bivariate logistic regression models to determine
odds ratios (OR) of presenting with late-stage HIV disease. To
Table 2. Perceived barriers to medical care among those with and without late-stage disease (CD4,100 cells/mm
3) at the time of
initial HIV diagnosis (N=830).
Perceived Barrier
Total Cohort
N( % )
Presented with late-
stage HIV disease
N( % )
Presented without late-
stage HIV disease
N (%) p-value
Odds Ratio (95%
CI)
Have to wait too long to see the nurse/doctor 261 (31.4) 104 (37.3) 157 (28.5) 0.010 1.49 (1.10–2.02)
Could not afford medications 216 (26.0) 94 (33.7) 122 (22.1) ,0.001 1.79 (1.30–2.46)
Didn’t think it was necessary, because
didn’t feel sick
205 (24.7) 68 (24.4) 137 (24.9) 0.877 0.97 (0.70–1.36)
Could not afford the cost of transportation 198 (23.9) 87 (31.2) 111 (20.1) ,0.001 1.80 (1.29–2.49)
Could not get to the clinic during the hours
it was open
183 (22.1) 74 (26.5) 109 (19.8) 0.027 1.46 (1.04–2.05)
Could not arrange transport to the clinic 158 (19.0) 69 (24.7) 89 (16.2) 0.003 1.71 (1.20–2.43)
Could not get time off work 135 (16.3) 49 (17.6) 86 (15.6) 0.471 1.15 (0.78–1.69)
Felt too sick 120 (14.5) 67 (24.0) 53 (9.6) ,0.001 2.97 (2.00–4.41)
Did not know where to find care 120 (14.5) 37 (13.3) 83 (15.1) 0.486 0.86 (0.57–1.31)
Had to take care of someone else 104 (12.5) 43 (15.4) 61 (11.1) 0.074 1.46 (0.96–2.23)
The nurse/doctor does not speak my language 71 (8.6) 26 (9.3) 45 (8.2) 0.575 1.16 (0.70–1.92)
Were not treated with respect by
the nurse/doctor
67 (8.1) 27 (9.7) 40 (7.3) 0.227 1.37 (0.82–2.28)
doi:10.1371/journal.pone.0055305.t002
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3) at the time of
initial HIV diagnosis (N=830).
Odds Ratio (95% CI) p-value
Adjusted Odds
Ratio (95% CI) p-value
Demographic
Age ,40 years Reference – Reference –
Age $40 years 1.33 (0.98–1.81) 0.070 1.07 (0.77–1.48) 0.701
Female Reference – Reference –
Male 1.53 (1.14–2.04) 0.004 1.66 (1.22–2.26) 0.001
Education
Completed high school Reference – – –
Did not complete high school 1.27 (0.95–1.70) 0.103 – –
Employment
Not currently working outside home Reference – Reference –
Currently working outside home 1.26 (0.94–1.68) 0.125 1.48 (1.07–2.05) 0.019
Working $20 hours outside home Reference – – –
Working ,20 hours outside home 2.46 (1.19–5.08) 0.015 – –
Proximity to the HIV Clinic
Distance to clinic ,5 kilometers Reference – Reference –
Distance to clinic $5 kilometers 3.25 (2.01–5.26) ,0.001 2.80 (1.68–4.67) ,0.001
Travel time to clinic ,30 minutes Reference – – –
Travel time to clinic $30 minutes 1.13 (0.84–1.52) 0.432 – –
Health Care Usage
Prior HIV testing Reference – – –
No prior HIV testing 1.68 (1.14–2.46) 0.008 – –
No overnight hospital stay in last year Reference – Reference –
Any overnight hospital stay in last year 1.68 (0.99–2.86) 0.055 1.64 (0.94–2.88) 0.084
Emotional Health and Social Support
Good Emotional Health ($ median value) Reference – Reference –
Poor Emotional Health (, median value) 1.64 (1.23–2.20) 0.001 1.41 (1.03–1.94) 0.034
Good Social Support ($ median value) Reference – Reference –
Poor Social Support (, median value) 1.66 (1.24–2.21) 0.001 1.35 (0.97–1.88) 0.072
Perceived Barriers to Medical Care
No service delivery barriers Reference – Reference –
Service delivery barriers 1.57 (1.16–2.11) 0.003 1.48 (1.07–2.05) 0.018
No financial barriers Reference – – –
Financial barriers 1.89 (1.38–2.58) ,0.001 – –
No personal health barriers Reference – – –
Personal health barriers 1.36 (1.00–1.84) 0.049 – –
No logistical barriers Reference – – –
Logistical barriers 1.39 (1.00–1.94) 0.049 – –
No structural barriers Reference – – –
Structural barriers 1.34 (0.99–1.82) 0.060 – –
Competing Needs to Health Care
Never gone without healthcare because needed
money for food, clothing, or housing
Reference – Reference –
Gone without healthcare because needed
money for food, clothing, or housing
1.44 (1.05–1.98) 0.024 1.67 (1.17–2.37) 0.004
Never foregone food, clothing, or housing because needed
money for healthcare
Reference – – –
Foregone food, clothing, or housing because needed
money for healthcare
1.31 (0.94–1.82) 0.115 – –
doi:10.1371/journal.pone.0055305.t003
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adjusted odds ratios (AOR), we included age, sex, and any
variable with a p-value ,0.15 in bivariate analyses into a single
model. We then removed one variable at a time for those variables
with a p-value .0.15, and after each variable was removed, the
model was refit to evaluate the remaining variables. Finally,
variables not selected based on the initial unadjusted analyses were
included in the multivariate model to assess their significance in
the presence of other variables, and all variables were retained if
they had p-values ,0.15. To minimize the potential for
collinearity, we assessed the correlation between all pairs of
independent variables and verified that no pair of variables
included in the same regression model was highly correlated with a
Spearman r .0.60. All reported p-values were two-tailed, and a p-
value ,0.05 was considered statistically significant. We conducted
analyses using SAS software (version 9.2; SAS Institute, Cary,
NC).
Results
Cohort characteristics
Among 3,669 people screened for the study, 2,694 met
eligibility criteria and enrolled in the study. Among those enrolled,
1,026 (38.1%) tested positive for HIV, of which 830 adults (80.9%
of HIV-infected participants) completed both CD4 testing and the
study survey. Among those, the median CD4 count was 186 cells/
mm
3 (interquartile range 70–345 cells/mm
3), and 279 (33.6%)
participants had late-stage HIV disease at the time of their initial
HIV diagnosis.
Within the cohort, 249 (30.0%) were .40 years of age, 415
(50.0%) were male, and 449 (54.1%) had not completed high
school (Table 1). Over half (56.5%) worked outside the home,
and 688 (82.9%) participants reported living $5 kilometers from
the clinic. Most participants (79.7%) had never previously been
tested for HIV, including 54 of the 60 participants (90.0%) who
had spent an overnight in a hospital during the prior year.
Reported HIV testing of participants hospitalized during the
prior year (6/60 or 10.0%) was significantly lower than the
reported HIV testing among participants who had not been
hospitalized during the prior year (162/769 or 21.1%) (p=0.04).
Competing needs to healthcare
Overall, 227 (27.3%) participants had ever gone without
healthcare because they needed money for basic necessities (food,
clothing, or housing). In bivariate analysis, this was more
common among those presenting with late-stage HIV disease
(p=0.02). Participants who presented with late-stage disease were
also more likely to have gone without healthcare to pay for food
(23.3% vs. 16.3%, p=0.02), housing (22.5% vs. 15.6%, p=0.04),
and food and housing (13.3% vs. 7.6%, p=0.009) (Figure 1, top).
Similarly, 196 participants (23.6%) had ever foregone basic
necessities because they needed money for healthcare. Partici-
pants who presented with late-stage disease were more likely to
have foregone housing (18.6% vs. 13.2%, p=0.04), and food and
housing (10.8% vs. 6.4%, p=0.03) to pay for healthcare
(Figure 1, bottom).
Perceived barriers to medical care
The most commonly reported perceived barriers to medical
care were ‘‘have to wait too long to see the nurse or doctor’’
(31.4%), ‘‘could not afford medications’’ (26.0%), and ‘‘didn’t
think it was necessary, because didn’t feel sick’’ (24.7%) (Table 2).
Participants who reported a perceived barrier of ‘‘felt too sick’’
had a 2.97-fold higher odds (95% CI 2.00–4.41) of late-stage
HIV disease presentation. Perceived barriers of ‘‘could not afford
the cost of transportation’’ (OR 1.80, 95% CI 1.29–2.29), ‘‘could
not afford medications’’ (OR 1.79, 95% CI 1.30–2.46), ‘‘could
not arrange transport to the clinic’’ (OR 1.71, 95% CI 1.20–
2.43), ‘‘have to wait too long to see the nurse/doctor’’ (OR 1.49,
95% CI 1.10–2.02), and ‘‘could not get to the clinic during the
hours it was open’’ (OR 1.46, 95% CI 1.04–2.05) were also more
commonly reported among those presenting with late-stage HIV
disease.
Factors associated with late-stage HIV disease
presentation
In the multivariate logistic regression model (Table 3), factors
associated with presentation to care with late-stage HIV disease
were living $5 kilometers from the clinic, having gone without
healthcare because money was needed for basic necessities, being
male, working outside the home, having a perception of health
service delivery barriers, and poor emotional health. Living
$5 kilometers from the clinic conferred a 2.80-fold (95% CI
1.68–4.67) higher odds of presenting with late-stage HIV disease.
Having gone without healthcare because money was needed for
basic necessities (AOR 1.67, 95% CI 1.17–2.37), being male
(AOR 1.66, 95% CI 1.22–2.26), and working outside the home
(AOR 1.48, 95% CI 1.07–2.05) had higher odds of late-stage HIV
disease presentation. Among the categories of perceived barriers to
medical care, only a perception of barriers related to health service
delivery (AOR 1.48, 95% CI 1.07–2.05), which included ‘‘have to
wait too long to see the nurse/doctor’’, was significantly associated
with late-stage HIV disease presentation in multivariate analyses.
Finally, while both poor emotional health and poor social support
were significant in bivariate analyses, only poor emotional health
(AOR 1.41, 95% CI 1.03–1.94) was significant in the multivariate
model.
Table 4. Identified barriers and possible solutions to reduce the risk of late-stage HIV disease presentation.
Identified Barriers Possible Solutions
N Living .5 kilometers from the test site N Provide mobile HIV testing services
N Reported competing needs to healthcare N Provide financial assistance to those at risk
N Worked outside the home N Offer periodic HIV screening at employment and business locations
N Perceived health service delivery barrier N Expand clinic HIV testing hours to include nights and weekends
N Provide travel vouchers to those presenting for HIV testing
N Poor emotional health N Increase depression screening in the community
N Strengthen integration of mental health services into primary health care
doi:10.1371/journal.pone.0055305.t004
Late-Stage HIV Disease Presentation
PLOS ONE | www.plosone.org 6 January 2013 | Volume 8 | Issue 1 | e55305Discussion
As both guidelines and data increasingly support earlier HIV
treatment, it is imperative to understand why patients continue to
present with advanced HIV. In a large cohort of outpatient clinic
attendees newly diagnosed with HIV in South Africa, the main
risk factors for presenting with late-stage HIV disease were living
further from the clinic, being male, and having gone without
healthcare to pay for basic living necessities. Other variables
associated with late-stage disease presentation were working
outside the home, having a perception of barriers to health
service delivery, such as long wait times, and having poor
emotional health. These findings provide focused targets for
improving HIV testing programs in order to diagnose people
earlier and reduce the number of adults presenting to care with
late-stage HIV disease.
Several studies have examined risk factors for late-stage disease
presentation in sub-Saharan Africa. In Uganda, studies by Kigozi
et al. and Wanyenze et al. found significant risk factors were being
male, older, and having no secondary education, similar to our
findings [21,22]. They additionally found that people receiving
healthcare in a non-medical setting (pharmacy, home, or by
traditional healer) or having many sexual partners, both of which
were variables we did not obtain, were more likely to present with
late-stage disease. In Ethiopia, which has a very different cultural
population than South Africa, non-pregnant women, frequent
alcohol users, those in a long-term relationship, and people who
perceived ART to have many side effects or HIV as a stigmatizing
disease were more likely to present with late-stage disease [23]. In
our cohort, relationships longer than 6 months had no impact on
late-stage presentation, and we did not assess alcohol use or
perception of HIV as a stigmatizing disease. The current study is
unique from these previous studies by assessing distance to the
clinic, perceived barriers to healthcare, competing needs to
healthcare, and emotional health and social support structures,
before participants were aware of their HIV-infected status.
In our cohort, several structural barriers, such as longer distance
to the clinic, a perception of poor service delivery, and working
outside the home, were among the strongest risk factors for late-
stage HIV disease. Other studies in Africa have shown similar
structural barriers, such as longer distances and higher transpor-
tation costs, to be related to loss-to-care before ART initiation
[24–28]. One potential approach to ensuring better service
delivery and earlier HIV diagnosis could be the use of active,
mobile HIV testing strategies [29–31].
Despite the frequent occurrence of late-stage HIV disease
presentation in sub-Saharan Africa, there has been an incomplete
and inconsistent understanding of the perceived personal barriers
to HIV testing [32]. In Botswana, perceived barriers to HIV
testing included fear of learning one’s status, lack of perceived HIV
risk, and fear of having to change sexual practices if positive [33].
In Ethiopia, a perception of HIV as a highly stigmatizing disease
was common among people who presented with late-stage disease
[23]. Although we did not assess HIV-related stigma, our findings
indicate that a perception of service delivery, structural, or
financial barriers are obstacles that prevented people from
learning their HIV-infected status.
Over one-quarter of those in our cohort reported having gone
without healthcare because they needed money for basic
necessities, and they were more likely to present with late-stage
disease. In several sub-Saharan African studies, food insecurity has
been associated with poor ART adherence, more opportunistic
infections, missed clinic visits, and increased hospitalizations [34–
36]. Food insecurity is more common among older, unmarried,
HIV-infected adults [34], and thus food insecurity should be
addressed as part of comprehensive HIV treatment programs in
resource-limited settings [37]. While our findings support the
observed negative effects of food insecurity, our results suggest that
housing insecurity is also a common problem and associated with
late-stage HIV disease presentation.
We found that poor emotional health and social support, both
of which were assessed before HIV testing, were associated with a
higher likelihood of presentation with late-stage HIV. Depression
is common among HIV-infected adults [38,39], and mental health
problems are vastly undertreated in resource-poor settings [40,41].
Rates of depression are also higher in symptomatic HIV-infected
people [42]. While little data exists on outcomes among HIV-
infected adults with mental health issues in developing countries,
one U.S.-based study found higher rates of mortality among HIV-
infected adults with depression [43]. Studies from Uganda and
Ethiopia have reported conflicting results about whether poor
mental health influences ART adherence [44,45]. While evidence
has been lacking on the association between mental health
disorders and uptake of diagnostic and treatment services for HIV
[40], our findings suggest that mental health issues and poor social
support structures may be important risk factors for delayed HIV
testing.
In our study, which excluded known HIV-infected adults, the
60 participants who had been hospitalized during the prior year
represented important missed opportunities for HIV testing.
Surprisingly, self-reported prior HIV testing was less common
among those who had been hospitalized, since South African
guidelines recommend ‘‘offering HIV testing to all clients
attending health-care facilities as a standard component of medical
care, unless the client actively refuses’’ [46]. Our finding suggests
that either providers were not adherent to national guidelines or
hospitalized patients refused HIV testing at very high rates (90%).
Regardless, those missed opportunities represented 7.2% of our
cohort, suggesting that HIV testing of hospitalized patients
remains suboptimal.
Our findings were primarily limited by the accuracy of self-
reported survey data. In this cross-sectional survey, we were not
able to determine causality with associations and the analysis was
not designed to fully examine the social stigma of HIV as a barrier
to testing. We used a definition of late-stage HIV disease of
CD4,100 cells/mm
3, which portends a major risk for cryptococ-
cal meningitis, a leading cause of AIDS-related deaths in sub-
Saharan Africa [47]. This definition allowed us to identify risk
factors and perceived barriers among the people with the greatest
risk for severe opportunistic infections and mortality. While we did
not assess some variables shown to be associated with late-stage
presentation in other African studies (alcohol consumption,
number of sexual partners, or ownership of material goods), we
examined many important measures not studied in other studies of
late-stage HIV disease presentation in sub-Saharan Africa. Finally,
a small number of HIV-infected participants either did not fully
complete our survey or agree to CD4 count testing, so we cannot
assess their influence on our findings.
In conclusion, we found independent risk factors for presenta-
tion with late-stage HIV disease from diverse domains, including
geographic, economic, demographic, social, and psychosocial.
These can directly inform efforts to improve HIV testing. Such
efforts should focus on various interventions, such as the use of
active mobile testing strategies, financial assistance, or providing
food supplementation, to reduce late-stage disease presentation in
resource-poor settings (Table 4). Simply expanding HIV testing
will not ensure ART-eligible people are enrolled in care or
initiated on ART; innovative approaches are also needed to
Late-Stage HIV Disease Presentation
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increased and targeted HIV testing to those at greatest risk for
late-stage HIV disease, and subsequently linking them to HIV care
should reduce AIDS-related morbidity and mortality.
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